RECRUITING

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.

Official Title

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

Quick Facts

Study Start:2025-06-06

Study Completion:2027-06-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06545604

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment. 2. Able to read, write, and speak English. 3. 18 years of age or older. 4. Oriented to person, place, and time. 5. Access to internet connection. 6. Access to a tablet, laptop or computer or smart phone. 7. Plan for surgical intervention at MD Anderson Cancer Center 8. Performance status 0-2.	1. Have completed chemotherapy. 2. Any major thought disorder (e.g., schizophrenia, dementia). 3. Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired). 4. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted).

Inclusion Criteria

Exclusion Criteria

1. Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment.
2. Able to read, write, and speak English.
3. 18 years of age or older.
4. Oriented to person, place, and time.
5. Access to internet connection.
6. Access to a tablet, laptop or computer or smart phone.
7. Plan for surgical intervention at MD Anderson Cancer Center
8. Performance status 0-2.

1. Have completed chemotherapy.
2. Any major thought disorder (e.g., schizophrenia, dementia).
3. Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired).
4. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted).

Contacts and Locations

Study Contact

Lois Ramondetta, MD

CONTACT

(713) 745-0307

lramonde@mdanderson.org

Principal Investigator

Lois Ramondetta, MD

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Lois Ramondetta, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-06

Study Completion Date2027-06-30

Study Record Updates

Study Start Date2025-06-06

Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

Ovarian Cancer